Research News

Evidence on value of skin cancer screening is insufficient, US panel finds

BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4155 (Published 27 July 2016) Cite this as: BMJ 2016;354:i4155
  1. Michael McCarthy
  1. Seattle

Evidence on the benefits and harms of routine skin cancer screening of adults is insufficient for assessment, the US Preventive Services Task Force has concluded in a report and evidence review published on 26 July in JAMA.1 2

Full body visual skin cancer screening has been a common practice among US physicians, with 56% of internists, 60% of primary care physicians, and 81% of dermatologists having reported performing the exam on their patients, a 2005 survey showed.3

In its review, the task force panel considered evidence related to screening for basal cell and squamous cell carcinomas (also known as non-melanoma skin cancer), as well as melanoma. Basal and squamous cell carcinomas accounted for …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe